Leadership transition in Gastroenterology: Muir to be new chief

Friday, May 9, 2014

After a decade as Chief of the Division of Gastroenterology, Anna Mae Diehl, MD, will be assuming a new role as director of the Duke Liver Center, with a goal to growing the sizable program in basic and translational research in chronic liver disease. With this new responsibility for Anna Mae, Mary Klotman, MD, chair of the department, will be appointing Andrew Muir, MD, MHS, to be the new chief of the division, effective July 1.

"I am grateful to Anna Mae for her dedicated leadership of the Division," said Dr. Klotman. "I am delighted that she has agreed to this new endeavor and that Andrew has agreed to step into the chief role. I know he’s eager to help, support and guide his GI colleagues through the challenges and opportunities ahead."

During Dr. Diehl's 10 years as chief, Gastroenterology doubled both its research portfolio and number of clinical faculty, while developing new clinical programs at Duke Regional Hospital and Duke Health Raleigh, launching Duke's first ambulatory endoscopy center at Brier Creek, and revitalizing the clinical GI program at the Durham VA Medical Center.

Diehl also recruited a national leader in transplant hepatology, initiated a divisional training program in molecular epidemiology of GI diseases and implemented a tissue biobanking initiative that is fueling new inter-disciplinary research in diseases of the liver, esophagus, and intestine. As director of the T32 training program in digestive disease research, she trained and recruited 5 MD scientists/clinical investigators to the faculty.

Her own scientific contributions to the field of liver disease have been recognized internationally, including by the NIH and the 2012 Distinguished Achievement Award from the American Association for the Study of Liver Diseases.

As director of the Duke Liver Center, Diehl will continue to seek innovations to understand the mechanisms of injury and repair in liver disorders.

Dr. Muir is associate professor with tenure, clinical director of hepatology, and director of the Gastroenterology & Transplant Hepatology Fellowship Programs. He has demonstrated substantial success in all three missions, as clinician, clinical researcher and medical educator and mentor. He is the director of Gastroenterology/Hepatology Research at the Duke Clinical Research Institute, is the co-PI on an NIH-funded RCT of an integrated treatment of persons with HCV and alcohol abuse, and he has been a leader in research in the therapies and response differences for hepatitis C virus infection.

Muir earned his M.D. here at Duke, and he stayed here for internal medicine residency and gastroenterology fellowship. He served as Chief Resident (1997-1998), and he has been a member of the faculty since 2000.

Learn more about Andrew in this MedicineNews profile.

The Division of Gastroenterology provides excellent care in a range of the major gastrointestinal and liver diseases. Learn more at http://gastroenterology.medicine.duke.edu/.